Prostate Cancer: A Conversation on Screenings, Treatment, and Advances

Cancer Care Connections

Early detection and self-advocacy are the keys to combating prostate cancer. As a medical oncologist, as well as president of Virginia Oncology Associates, Dr. Fleming not only shares his professional insights but also his personal journey dealing with prostate cancer. He emphasizes the importance of the PSA test, which plays a critical role in early diagnosis.
Dr. Mark T. Fleming is board-certified in Medical Oncology. He received his B.A. at Philadelphia’s prestigious University of Pennsylvania and his Doctorate in Medicine at the Medical University of Ohio. Dr. Fleming completed his residency at Temple University Hospital, Philadelphia, PA, and his Medical Oncology Fellowship at Memorial Sloan-Kettering Cancer Center, New York, NY. He then joined Virginia Oncology Associates (VOA) in August 2006.

Cancers of the Bladder, Kidney, Prostate, and Testicles, as well as Phase 1 novel drug development, are Dr. Fleming’s special clinical interest and expertise. He is heavily involved in cancer research serving as a principal investigator for clinical trials, locally and nationally, collaborating with institutions like Duke University Network, Hoosier Oncology Group, Prostate Cancer Clinical Trials Consortium, and Sarah Cannon Research to provide the latest treatment options to patients.

Dr. Fleming currently serves as the Medical Director of US Oncology’s Genitourinary (Bladder, Kidney, Prostate, and Testicular Cancers) Research Committee. He is also pivotal in coordinating the VOA’s genitourinary research program and backing up the Phase 1 program. In addition to his clinical and research activities, Dr. Fleming is an active leader within the medical community previously serving as both the Division Chief of Eastern Virginia Medical School Department of Hematology & Oncology and President of the Medical staff at Sentara Careplex Hospital. As a co-founding member and past president of the Hampton Roads Prostate Health Forum, Dr. Fleming is a passionate speaker on the importance of cancer education and the Early Detection of Prostate Cancer.
Resources mentioned in this podcast

Prostate Cancer Foundation: https://www.pcf.org/

NCCN (National Comprehensive Cancer Network): The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) are comprised of recommendations for the prevention, diagnosis, and management of malignancies across the continuum of care. https://www.nccn.org/

Hampton Roads Prostate Health Forum: https://www.hrprostatehealth.com/

Thank you for listening! If you're interested in hearing more from Virginia Oncology Associates, make sure to subscribe to Cancer Care Connections on Apple Podcasts, Spotify, or anywhere podcasts are available, or listen online at cancercareconnections.buzzsprout.com.
Cancer Care Connections is the official podcast of Virginia Oncology Associates. For more information, visit us at VirginiaCancer.com. or find us on Facebook or Instagram at Virginia Oncology Associates.

Kapitel

1. Prostate Cancer: A Conversation on Screenings, Treatment, and Advances (00:00:00)

2. PSA Test for Prostate Cancer (00:02:39)

3. Treatments for Early Localized Prostate Cancer (00:03:39)

4. New Drugs and Technologies for Prostate Cancer (00:07:16)

5. Genetic Testing for Prostate Cancer (00:14:56)

6. Resources for Prostate Cancer (00:16:02)